Dirk Kuyper to Step Down from CONMED Corporation Board of Directors Effective August 1, 2019
18 Junho 2019 - 9:00AM
Business Wire
CONMED Corporation (NASDAQ: CNMD) today announced that
independent director, Dirk M. Kuyper, has submitted a notice of
resignation, which will take effect on August 1, 2019.
“Dirk has been a highly valued voice in the board room for the
past six years, and we are grateful for his service to CONMED,”
commented Mark Tryniski, Chair of CONMED’s Board of Directors,
“Dirk has provided truly valuable insights and strategic direction
to management throughout his tenure on the Board, and, on behalf of
the entire Board of Directors and our leadership team, I thank Dirk
for his important contributions to CONMED’s success. We appreciate
and respect his desire to devote more time and focus to his growing
business interests, and we wish him all the best in those
pursuits.”
“My tenure on CONMED’s Board has been a tremendously positive
experience,” Mr. Kuyper said. “I have great confidence in Curt
Hartman’s vision and strategy for CONMED, and I believe he has the
right team in place to achieve his vision of sustainable long-term
growth.”
CONMED further announced that its Corporate Governance and
Nominating Committee has retained Trewstar Corporate Board
Services, a search firm that works exclusively at the Board level
and specializes in the placement of candidates offering gender and
ethnic diversity, to conduct a search to fill the director position
being vacated as a result of Mr. Kuyper’s resignation.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
neurosurgery, thoracic surgery and gastroenterology. For more
information, visit www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based
on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from
those in the forward-looking statements may include, but are not
limited to, the risk factors discussed in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2018 and
listed under the heading Forward-Looking Statements in the
Company’s most recently filed Quarterly Report on Form 10-Q. Any
and all forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995 and relate to the Company’s performance on a going-forward
basis. The Company believes that all forward-looking statements
made by it have a reasonable basis, but there can be no assurance
that management’s expectations, beliefs or projections as expressed
in the forward-looking statements will actually occur or prove to
be correct.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190618005109/en/
CONMED CorporationTodd GarnerChief Financial
Officer315-624-3317ToddGarner@conmed.com
CONMED (NASDAQ:CNMD)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
CONMED (NASDAQ:CNMD)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024